Insider Trading & Ownership - Kirchgraber Paul R

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Kirchgraber Paul R
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-05-19
Sale
2023-05-23
08:06 am
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
4,300$216.91$932,70712,946
(Direct)
View
2023-02-21
Sale
2023-02-23
09:54 am
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
8,000$250.58$2,004,67513,369
(Direct)
View
2021-05-06
Sale
2021-05-10
08:21 am
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
2,500$276.55$691,3757,844
(Direct)
View
2020-11-04
Sale
2020-11-06
09:06 am
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
1,500$214.14$321,2047,698
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-05-19
Exercise
2023-05-23
08:06 am
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
4,300$182.5112,946
(Direct)
View
2023-05-19
Exercise
2023-05-23
08:06 am
2021-02-04
2030-02-03
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
4,300$012,946
(Direct)
View
2023-03-30
Option Award
2023-04-03
10:13 am
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
6,763$012,946
(Direct)
View
2023-03-30
Tax Withholding
2023-04-03
10:13 am
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
2,886$224.712,946
(Direct)
View
2023-02-21
Exercise
2023-02-23
09:54 am
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
3,000$182.5113,369
(Direct)
View
2023-02-21
Exercise
2023-02-23
09:54 am
2021-02-04
2030-02-03
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
3,000$013,369
(Direct)
View
2023-02-13
Tax Withholding
2023-02-14
2:57 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
142$248.1317,070
(Direct)
View
2023-02-11
Exercise
2023-02-14
2:57 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
483$017,070
(Direct)
View
2023-02-07
Option Award
2023-02-09
12:02 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
6,590$08,484
(Direct)
View
2023-02-06
Tax Withholding
2023-02-07
2:51 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
164$244.515,622
(Direct)
View
2023-02-04
Exercise
2023-02-07
2:51 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
560$015,622
(Direct)
View
2023-02-02
Tax Withholding
2023-02-06
3:45 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
141$254.9915,786
(Direct)
View
2023-02-02
Exercise
2023-02-06
3:45 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
443$015,786
(Direct)
View
2022-11-01
Tax Withholding
2022-11-03
5:00 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
892$222.5615,927
(Direct)
View
2022-11-01
Exercise
2022-11-03
5:00 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
2,007$015,927
(Direct)
View
2022-03-28
Tax Withholding
2022-03-29
12:04 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
1,648$276.4211,915
(Direct)
View
2022-03-27
Option Award
2022-03-29
12:04 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
3,707$011,915
(Direct)
View
2022-02-11
Option Award
2022-02-15
4:42 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
6,550$025,081
(Direct)
View
2022-02-14
Tax Withholding
2022-02-15
4:42 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
108$272.6825,081
(Direct)
View
2022-02-12
Exercise
2022-02-15
4:42 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
317$025,081
(Direct)
View
2022-02-04
Tax Withholding
2022-02-08
11:13 am
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
165$277.4813,418
(Direct)
View
2022-02-04
Exercise
2022-02-08
11:13 am
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
560$013,418
(Direct)
View
2022-02-02
Tax Withholding
2022-02-04
09:44 am
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
144$273.1813,583
(Direct)
View
2022-02-02
Exercise
2022-02-04
09:44 am
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
443$013,583
(Direct)
View
2021-11-01
Tax Withholding
2021-11-03
11:47 am
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
898$288.7813,727
(Direct)
View
2021-11-01
Exercise
2021-11-03
11:47 am
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
2,007$013,727
(Direct)
View
2021-04-03
Tax Withholding
2021-04-06
12:18 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
452$252.6717,125
(Direct)
View
2021-04-03
Exercise
2021-04-06
12:18 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
1,010$017,125
(Direct)
View
2021-03-27
Tax Withholding
2021-03-30
6:42 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
790$251.589,786
(Direct)
View
2021-03-27
Option Award
2021-03-30
6:42 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
2,104$09,786
(Direct)
View
2021-02-12
Tax Withholding
2021-02-17
4:25 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
180$238.2624,371
(Direct)
View
2021-02-12
Exercise
2021-02-17
4:25 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
581$024,371
(Direct)
View
2021-02-04
Tax Withholding
2021-02-08
3:39 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
187$223.7816,443
(Direct)
View
2021-02-04
Exercise
2021-02-08
3:39 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
560$016,443
(Direct)
View
2021-02-02
Option Award
2021-02-04
5:14 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
5,930$013,532
(Direct)
View
2020-11-02
Exercise
2020-11-04
5:40 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
2,006$016,800
(Direct)
View
2020-11-02
Tax Withholding
2020-11-04
5:40 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
895$207.2316,800
(Direct)
View
2020-04-03
Tax Withholding
2020-04-07
4:21 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
372$113.3117,695
(Direct)
View
2020-04-03
Exercise
2020-04-07
4:21 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
1,010$017,695
(Direct)
View
2020-03-30
Option Award
2020-04-01
2:29 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
3,402$07,449
(Direct)
View
2020-03-30
Tax Withholding
2020-04-01
2:29 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
1,014$131.957,449
(Direct)
View
2020-02-12
Tax Withholding
2020-02-14
3:48 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
159$187.5126,613
(Direct)
View
2020-02-12
Exercise
2020-02-14
3:48 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
579$026,613
(Direct)
View
2020-02-07
Tax Withholding
2020-02-11
1:43 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
103$182.3315,838
(Direct)
View
2020-02-07
Exercise
2020-02-11
1:43 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
337$015,838
(Direct)
View
2020-02-04
Option Award
2020-02-06
2:33 pm
N/A
N/A
LABORATORY CORP OF AMERICA HOLDINGSLHKirchgraber Paul R
CEO, Covance Drug Development
8,980$018,834
(Direct)
View